2018 Zika Market Spotlight Report
further press releases» Press Release probably eleven, 2018 17 |44 UTC 2018 Zika Market Spotlight Report - ResearchAndMarkets.com DUBLIN--(Business Wire)--The ResearchAndMarkets.com's offering. DUBLIN--(Business Wire)--The "Market Spotlight: Zika" report has been added tooffering. This Market Spotlight report covers the Zika market, comprising key pipeline therapies, clinical trials, & licensing & acquisition deals. Candidates comprise DNA vaccines like NIH's Zika pollen & GeneOne's GLS-5700; Moderna's mRNA pollen; Themis Bioscience's recombinant viral vector pollen; Imutex's AGS-v pollen; Johnson & Johnson's Ad26.ZIKV.001 pollen; & Takeda's TAK-426 pollen. There were 8 licensing & asset acquisition activities involving Zika drugs during 2013-17, all of that occurred in either 2016 or 2017.Screening Blood Donations for Zika Is expensive, Low Yield
referring to Screening Blood Donations for Zika Is expensive, Low YieldShare this content |linkedingoogleEmailPrintNine donations were approved positive; six of these had travelled to ZIKV-active areas. (HealthDay break news) -- Screening blood donations for Zika (ZIKV) in the U.S. is expensive by low yield, according to a research published in the Fresh Britain Journal of Medicine. Repeat TMA, TMA Analyzing in exploratory minipools, real-time reverse-transcriptase polymerase chain reaction, immunoglobulin M (IgM) serologic Analyzing, & red-cell TMA were performed as confirmatory Analyzing of reactive donations. The investigators found which nine% of the four,325,889 donations which were screened were initially tested in minipools, & there were no reactive donations. "Screening of America blood donations for ZIKV by individual-donation TMA was expensive & had a low yield," the authors write.Zika Test Indicated for Pooled Collection test with Food and Drug Administration
probably 14, 2018Kevin KunzmannThe America FDA (FDA) has confirmed an extra appeal for Roche's cobas Zika virus Analysis for its Utilize on the cobas 6800/8800 Systems. In information gathered from the Utilizes, as well as extra industrialist researches, the Analysis returned a clinical specifity of 99%. Its Certain capabilities in this initial observation led to the reinstatement of blood services on the island.Zika virus, a virus contagion the results in newborn defects & neurological Disorders in both Kids & adults, is transmitted out of sexistintercourse, birth, & susceptibly out of donor blood transfusions. The cobas Zika virus Analysis received consent from the FDA in October 2017 , allowing its Utilize in donor screening out of the continental America & Puerto Rico. The fully-automated systems are designed for high-volume automated sample pooling out of sample preparation, polymerase chain reaction amplification, & revelation.collected by :Lucy William